Identification of putative gene-based markers of renal toxicity

Environmental Health Perspectives

Volumn 112, Issue 4, 2004, Pages 465-479

  Amin, Rupesh P ^a   Vickers, Alison E ^b   Sistare, Frank ^c   Thompson, Karol L ^c   Roman, Richard J ^d   Lawton, Michael ^e   Kramer, Jeffrey ^e   Hamadeh, Hisham K ^a,f   Collins, Jennifer ^a   Grissom, Sherry ^a   Bennett, Lee ^a   Tucker, C Jeffrey ^a   Wild, Stacie ^f   Kind, Clive ^g   Oreffo, Victor ^g   Davis II, John W ^h   Curtiss, Sandra ^e   Naciff, Jorge M ⁱ   Cunningham, Michael ^a   Tennant, Raymond ^a   Stevens, James ^j   Car, Bruce ^k   Bertram, Timothy A ^e   Afshari, Cynthia A ^a,f   more..

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e PFIZER INC   (United States)

^f AMGEN INC   (United States)

^g ASTRAZENECA   (United Kingdom)

^h MERCK RESEARCH LABORATORIES   (United States)

ⁱ PROCTER AND GAMBLE COMPANY   (United States)

^j ELI LILLY AND COMPANY   (United States)

^k BRISTOL MYERS SQUIBB   (United States)

more..

Author keywords

Biomarkers; Cisplatin; Gentamicin; Microarrays; Nephrotoxicity; Proximal tubule; Puromycin; Toxicogenomics

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; GENTAMICIN; PUROMYCIN; RNA; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG EXPOSURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; KIDNEY INJURY; LONG TERM EXPOSURE; MALE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAT; RAT STRAIN; RNA EXTRACTION; SAMPLE; UNINDEXED SEQUENCE; URINALYSIS;

ANIMALIA; GLOMERULUS;

EID: 12144290763     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6683     Document Type: Article

References (80)

1. Affymetrix 2003. Technical Documentation Manuals. Santa Clara, CA:AFfymetrix Inc. Available: http://www.affymetrix.com/support/technical/manuals.affx [accessed 5 September 2003].
2. Andoh TF, Gardner MP, Bennett WM. 1997. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 64:1236-1240.
3. Applied Biosystems. 1997. User Bulletin #2: Relative Quantitation of Gene Expression. Foster City, CA:APplied Biosystems.
4. Aulitzky WK, Schlegel PN, Wu DF, Cheng CY, Chen CL, Li PS, et al. 1992. Measurement of urinary clusterin as an index of nephrotoxicity. Proc Soc Exp Biol Med 199:93-96.
5. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. 2002. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277:39739-39748.
6. Bushel PR, Hamadeh HK, Bennett L, Green J, Ableson A, Misener S, et al. 2002. Computational selection of distinct class- and subclass-specific gene expression signatures. J Biomed Inform 35:160-170.
7. Bushel PR, Hamadeh H, Bennett L, Sieber S, Martin K, Nuwaysir EF, et al. 2001. MAPS: A microarray project system for gene expression experiment information and data validation. Bioinformatics 17:564-565.
8. Chen Y, Dougherty ER, Bittner ML. 1997. Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt 2:364-374.
9. Christensson A, Ekberg J, Grubb A, Ekberg H, Lindstrom V, Lilja H. 2003. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol 94:19-27.
10. Clements, JA. 1989. The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation. Endocr Rev 10:393-419.
11. Correa-Rotter R, Ibarra-Rubio ME, Schwochau G, Cruz C, Silkensen A Pedraza-Chaverri J, et al. 1998. Induction of clusterin in tubules of nephrotic rats. J Am Soc Nephrol 9:33-37.
12. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, et al. 1996. Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat Genet 14:457-460.
13. Devireddy LR, Teodoro JG, Richard FA, Green MR. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293:829-834.
14. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
15. Flower DR. 1996. The lipocalin protein family: Structure and function. Biochem J. 318:1-14.
16. Flower DR, North AC, Sansom CE. 2000. The lipocalin protein family: Structural and sequence overview. Biochim Biophys Acta 1482:9-24.
17. Girton RA, Sundin DP, Rosenberg ME. 2002. Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. Am J Physiol Renal Physiol 282: 703-709.
18. Hamadeh HK, Bushel PR, Jayadev S, DiSorbo O, Bennett L, Li L, et al. 2002a. Prediction of compound signature using high density gene expression profiling. Toxicol Sci 67:232-240.
19. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. 2002b. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231.
20. Hamadeh HK, Knight BL, Haugen AC, Sieber S, Amin RP, Bushel PR, et al. 2002. Methapyrilene toxicity: Anchorage of pathologic observations to gene expression alterations. Toxicol Pathol 30:470-482.
21. Hammerman MR. 1998a. Potential role of growth factors in the prophylaxis and treatment of acute renal failure. Kidney Int Suppl 64:S19-S22.
22. Hammerman MR. 1998b. Growth factors and apoptosis in acute renal injury. Curr Opin Nephrol Hypertens 7:419-424.
23. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. 2002. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-244.
24. Hoffmann A, Conradt HS, Gross G, Nimtz M, Lottspeich F, Wurster U. 1993. Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: Its identification as prostaglandin D synthase. J Neurochem 61:451-456.
25. Hoffmann A, Nimtz M, Conradt HS. 1997. Molecular characterization of beta-trace protein in human serum and urine: A potential diagnostic marker for renal diseases. Glycobiology 7:499-506.
26. Huang Q, Dunn RT 2nd, Jayadev S, DiSorbo O, Pack FD, Farr SB, et al. 2001. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196-207.
27. Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE. 1999. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10:444-457.
28. Huckins KL, Le QC, Segerer S, Johnson RJ, Davis CL, Giachelli CM, et al. 2001. Osteopontin expression in human cyclosporine toxicity. Kidney Int 60:635-640.
29. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273:4135-4142.
30. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA. 2002. Expression of osteopontin in rat kidneys: Induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173-1181.
31. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Moura LA, Pereira AB. 2002. Urinary retinol-binding protein as a prognostic marker in glomerulopathies. Nephron 90:424-431.
32. Kramer JA, Petit SD, Amin RP, Bertram TA, Car B, Cunningham M, et al. 2004. Overview of the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect 112:460-464.
33. Laterza OF, Price CP, Scott MG. 2002. Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 48:699-707.
34. Lee H, Kim JH, Chae YJ, Ogawa H, Lee MH, Gerton GL. 1998. Creatine synthesis and transport systems in the male rat reproductive tract. Biol Reprod 58:1437-1444.
35. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680.
36. Magil AB, Pichler RH, Johnson RJ. 1997. Osteopontin in chronic puromycin aminonucleoside nephrosis. J Am Soc Nephrol 8:1383-1390.
37. Makover A, Soprano DR, Wyatt ML, Goodman DS. 1989. Localization of retinol-binding protein messenger RNA in the rat kidney and in perinephric fat tissue. J Lipid Res 30:171-180.
38. Matejka GL. 1998. Expression of GH receptor, IGF-I receptor and IGF-I mRNA in the kidney and liver of rats recovering from unilateral renal ischemia. Growth Horm IGF Res 8:77-82.
39. Mattenheimer H. 1968. Enzymology of kidney tissue. Curr Probl Clin Biochem 2:119-145.
40. Melegos DN, Grass L, Pierratos A, Diamandis EP. 1999. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53:32-37.
41. Murakami H, Yayama K, Chao L, Chao J. 1998. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats. Kidney Int 53:1305-1313.
42. Muramatsu Y, Tsujie M, Kohda Y, Pham B, Perantoni AO, Zhao H, et al. 2002. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62:1601-1610.
43. Nagasawa Y, Takenaka M, Kaimori J, Matsuoka Y, Alkagi Y, Tsujie M, et al. 2001. Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis. Nelphrol Dial Transplant 16:923-931.
44. Nagata A, Suzuki Y, Igarashi M, Eguchi N, Toh H, Urade Y, et al. 1991. Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins. Proc Natl Acad Sci USA 88:4020-4024.
45. Nakao A, Watanabe T, Ohishi N, Toda A, Asano K, Taniguchi S, et al. 1999. Ubiquitous localization of leukotriene A4 hydrolase in the rat nephron. Kidney Int 55:100-108.
46. NIEHS Microarray Group. 2003a. NIEHS Chips and Clones. Research Triangle Park, NC:NAtional Center for Toxicogenomics, National Institute of Environmental Health Sciences. Available: http://dir.niehs.nih.gov/microarray/chips.htm [accessed 5 September 2003].
47. NIEHS Microarray Group. 2003b. Methods and Protocols. Research Triangle Park, NC:NAtional Center for Toxicogenomics, National Institute of Environmental Health Sciences. Available: http://dir.niehs.nih.gov/microarray/methods.htm [accessed 5 September 2003].
48. NIEHS Microarray Group. 2003c. ILSI Datasets. Research Triangle Park, NC:NAtional Center for Toxicogenomics, National Institute of Environmental Health Sciences. Available: http://dir.niehs.nih.gov/microarray/ilsi-datasets/home.htm [accessed 5 September 2003].
49. NIH. 1999. NIH Guide for the Care and Use of Laboratory Animals. Bethesda, MD:NAtional Institutes of Health.
50. Newman DJ. 2002. Cystatin C. Ann Clin Biochem 39:89-104.
51. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sahested M, Kjeldsen L. 1996. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420.
52. Norman JT, Bohman RE, Fischmann G, Bowen JW, McDonough A, Slamon D, et al. 1988. Patterns of mRNA expression during early cell growth differ in kidney epithelial cells destined to undergo compensatory hypertrophy versus regenerative hyperplasia. Proc Natl Acad Sci USA 85:6768-6772.
53. Oda H, Shiina Y, Seiki K, Sato N, Eguchi N, Urade Y. 2002. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin Chem 48:1445-1453.
54. Ortiz A, Lorz C, Justo P, Catalan MP, Egido J. 2001. Contribution of apoptotic cell death to renal injury. J Cell Mol Med 5:18-32.
55. Pennie WD, Pettit SD, Lord PG. 2004. Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Environ Health Perspect 112:417-419.
56. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, et al. 1995. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196.
57. Ritchie HH, Hou H, Veis A, Butler WT. 1994. Cloning and sequence determination of rat dentin sialoprotein, a novel dentin protein. J Biol Chem 269:3698-3702.
58. Rosenberg ME, Girton R, Finkel D, Chmielewski D, Barrie A 3rd, Witte DP, et al. 2002. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol 22:1893-1902.
59. Rosenberg ME, Silkensen J. 1995. Clusterin and the kidney. Exp Nelphrol 3:9-14.
60. Rosenberg ME, Silkensen J. 1995. Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27:633-645.
61. Safirstein R, Price PM, Saggi SJ, Harris RC. 1990. Changes in gone expression after temporary renal ischemia. Kidney Int 37:1515-1521.
62. Saunders JR, Aminian A, McRae JL, O'Farrell KA, Adam WR, Murphy BF. 1994. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45:817-827.
63. Schmaier AH. 2003. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am J Physiol Regul Integr Comp Physiol 285:R1-R13.
64. Silkensen JR, Agarwal A, Nath KA, Manivel JC, Rosenberg ME. 1997. Temporal induction of clusterin in cisplatin nephrotoxicity. J Am Soc Nephrol 8:302-305.
65. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM. 1996. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 9:139-142.
66. Star R, Hostetter T, Hortin GL. 2002. New markers for kidney disease. Clin Chem 48:1375-1376.
67. Thompson KL, Afshari CA, Amin RP, Bertram TA, Car B, Cunningham M, et al. 2004. Identification of platform-independent gone expression markers of cisplatin nephrotoxicity. Environ Health Perspect 112:488-496.
68. Toback FG. 1992, Regeneration after acute tubular necrosis. Kidney Int 41:226-246.
69. Tome LA, Yu L, do Castro I, Campos SB, Seguro AC. 1999. Beneficial and harmful effects of L-arginine on renal ischaemia. Nephrol Dial Transplant 14:1139-1145.
70. Urade Y, Hayaishi O. 2000. Prostaglandin D synthase: structure and function. Vitam Horm 58:89-120.
71. Valdivielso JM, Blantz RC. 2002. Acute renal failure: Is nitric oxide the bad guy? Antioxid Redox Signal 4:925-934.
72. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. 2001a. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120:359-368.
73. Waring JF, Jolly RA, Ciurlionis R, Lum PY, Praestgaard JT, Morfitt DC, et al. 2001b. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 175:28-42.
74. WHO. 1991. Principles and Methods for the Assessment of Nephrotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria 119. Geneva:WOrld Health Organization, International Programme on Chemical Safety.
75. Yan L, Borregaard N, Kjeldsen L, Moses MA. 2001. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265.
76. Yang J, Mori K, Li JY, Barasch J. 2003. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285:F9-F18.
77. Yasuda M, Sugahara K, Zhang J, Shuin T, Kodama H. 2000. Effect of cisplatin treatment on the urinary excretion of guanidinoacetic acid, creatinine and creatine in patients with urinary tract neoplasm, and on superoxide generation in human neutrophils. Physiol Chem Phys Med NMR 32:119-125.
78. Yoshida T, Kurella M, Beato F, Min H, Ingelfinger JR, Stears RL, et al. 2002. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int 61:1646-1654.
79. Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW. 2000. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics 69:225-234.
80. Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, et al. 2002. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int 61:1030-1039.